Cerebrospinal Fluid (CSF) Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

NEW YORK, July 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Cerebrospinal Fluid (CSF) Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

http://www.reportlinker.com/p0567529/Cerebrospinal-Fluid-CSF-Management-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

Cerebrospinal Fluid (CSF) Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Summary

GlobalData's new report, "Cerebrospinal Fluid (CSF) Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017" provides key market data on the Cerebrospinal Fluid (CSF) Management market in the BRICS countries. The report provides value (USD million), volume (units) and average price (USD) data for each segment within two market categories – Dura Substitutes and Hydrocephalus Shunts. The report also provides company shares and distribution shares data for the overall Cerebrospinal Fluid (CSF) Management market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

The emerging economies, comprising of China, India, Brazil, Russia, and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world's most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It's estimated that by 2020, India's population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size data for Cerebrospinal Fluid (CSF) Management market categories – Dura Substitutes and Hydrocephalus Shunts.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within the two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for the overall Cerebrospinal Fluid (CSF) Management market in each of the aforementioned countries.

- Global corporate-level profiles of key companies operating within the Cerebrospinal Fluid (CSF) Management market in BRICS.

- Key players covered include Medtronic, Inc., Integra LifeSciences Holdings Corporation, B. Braun Melsungen AG, Sophysa S.A.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Cerebrospinal Fluid (CSF) Management competitive landscape in BRICS.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 9

2 Introduction 12

2.1 What is This Report About? 12

3 CSF Management In BRICS 13

3.1 CSF Management, BRICS, Overall Revenue ($m), 2003-2017 13

3.2 CSF Management, BRICS, Category Volume (Units), 2003-2017 19

3.3 CSF Management, BRICS, Company Share (2009-2010) 23

4 CSF Management In Brazil 25

4.1 CSF Management, Brazil, Overall Revenue (2003-2017) 25

4.2 CSF Management, Brazil Overall Volume (2003-2017) 29

4.3 Dura Substitutes in Brazil 32

4.3.1 Dura Substitutes, Brazil, Overall Revenue (2003-2017) 32

4.3.2 Dura Substitutes, Brazil, Overall Volume (2003-2017) 34

4.3.3 Dura Substitutes, Brazil, Average, Price (2003-2017) 36

4.4 Hydrocephalus Shunts in Brazil 37

4.4.1 Hydrocephalus Shunts, Brazil, Overall Revenue (2003-2017) 37

4.4.2 Hydrocephalus Shunts, Brazil, Overall Volume (2003-2017) 39

4.4.3 Hydrocephalus Shunts, Brazil, Average, Price (2003-2017) 41

4.5 CSF Management, Brazil, Distribution Share (2009-2010) 42

4.6 CSF Management, Brazil, Company Share (2009-2010) 43

5 CSF Management In Russian Federation 45

5.1 CSF Management, Russian Federation, Overall Revenue (2003-2017) 45

5.2 CSF Management, Russian Federation, Overall Volume (2003-2017) 49

5.3 Dura Substitutes In Russian Federation 53

5.3.1 Dura Substitutes, Russian Federation, Overall Revenue (2003-2017) 53

5.3.2 Dura Substitutes, Russian Federation, Overall Volume (2003-2017) 55

5.3.3 Dura Substitutes, Russian Federation, Average, Price (2003-2017) 57

5.4 Hydrocephalus Shunts in Russian Federation 58

5.4.1 Hydrocephalus Shunts, Russian Federation, Overall Revenue (2003-2017) 58

5.4.2 Hydrocephalus Shunts, Russian Federation, Overall Volume (2003-2017) 60

5.4.3 Hydrocephalus Shunts, Russian Federation, Average, Price (2003-2017) 62

5.5 CSF Management, Russian Federation, Distribution Share (2009-2010) 63

5.6 CSF Management, Russian Federation, Company Share (2009-2010) 64

6 CSF Management In India 65

6.1 CSF Management, India, Overall Revenue (2003-2017) 65

6.2 CSF Management, India, Overall Volume (2003-2017) 70

6.3 Dura Substitutes in India 73

6.3.1 Dura Substitutes, India, Overall Revenue (2003-2017) 73

6.3.2 Dura Substitutes, India, Overall Volume (2003-2017) 75

6.3.3 Dura Substitutes, India, Average, Price (2003-2017) 77

6.4 Hydrocephalus Shunts in India 78

6.4.1 Hydrocephalus Shunts, India, Overall Revenue (2003-2017) 78

6.4.2 Hydrocephalus Shunts, India, Overall Volume (2003-2017) 80

6.4.3 Hydrocephalus Shunts, India, Average, Price (2003-2017) 82

6.5 CSF Management, India, Distribution Share (2009-2010) 83

6.6 CSF Management, India, Company Share (2009-2010) 84

7 CSF Management In China 85

7.1 CSF Management, China, Overall Revenue (2003-2017) 85

7.2 CSF Management, China, Overall Volume (2003-2017) 90

7.3 Dura Substitutes in China 93

7.3.1 Dura Substitutes, China, Overall Revenue (2003-2017) 93

7.3.2 Dura Substitutes, China, Overall Volume (2003-2017) 95

7.3.3 Dura Substitutes, China, Average, Price (2003-2017) 97

7.4 Hydrocephalus Shunts in China 98

7.4.1 Hydrocephalus Shunts, China, Overall Revenue (2003-2017) 98

7.4.2 Hydrocephalus Shunts, China, Overall Volume (2003-2017) 100

7.4.3 Hydrocephalus Shunts, China, Average, Price (2003-2017) 102

7.5 CSF Management, China, Distribution Share (2009-2010) 103

7.6 CSF Management, China, Company Share (2009-2010) 104

8 CSF Management In South Africa 106

8.1 CSF Management, South Africa, Overall Revenue (2003-2017) 106

8.2 CSF Management, South Africa, Overall Volume (2003-2017) 109

8.3 Dura Substitutes in South Africa 112

8.3.1 Dura Substitutes, South Africa, Overall Revenue (2003-2017) 112

8.3.2 Dura Substitutes, South Africa, Overall Volume (2003-2017) 114

8.3.3 Dura Substitutes, South Africa, Average, Price (2003-2017) 116

8.4 Hydrocephalus Shunts in South Africa 117

8.4.1 Hydrocephalus Shunts, South Africa, Overall Revenue (2003-2017) 117

8.4.2 Hydrocephalus Shunts, South Africa, Overall Volume (2003-2017) 119

8.4.3 Hydrocephalus Shunts, South Africa, Average, Price (2003-2017) 121

8.5 CSF Management, South Africa, Distribution Share (2009-2010) 122

8.6 CSF Management, South Africa, Company Share (2009-2010) 123

9 Overview of Key Companies in BRICS CSF Management Market 125

9.1 Medtronic, Inc. 125

9.1.1 Company Overview 125

9.1.2 Share in the BRICS CSF Management Market 126

9.2 Integra LifeSciences Holdings Corporation 127

9.2.1 Company Overview 127

9.2.2 Share in the BRICS CSF Management Market 128

9.3 B. Braun Melsungen AG 129

9.3.1 Company Overview 129

9.3.2 Share in the BRICS CSF Management Market 130

9.4 Sophysa S.A. 131

9.4.1 Company Overview 131

9.4.2 Share in the BRICS CSF Management Market 132

10 Appendix 133

10.1 Definitions of Markets Covered in the Report 134

10.1.1 CSF Management 134

10.2 Research Methodology 135

10.3 Secondary Research 135

10.4 Primary Research 136

10.5 Models 136

10.6 Forecasts 137

10.7 Expert Panels 137

10.8 GlobalData Consulting 137

10.9 Currency Conversion 137

10.10 Contact Us 138

10.11 Disclaimer 138

1.1

List of Tables

Table 1: CSF Management, BRICS, Overall Revenue ($m), 2003-2017 14

Table 2: CSF Management, BRICS, Overall Revenue ($m), Historic, 2003-2010 16

Table 3: CSF Management, BRICS, Overall Revenue ($m), Forecast, 2010-2017 18

Table 4: CSF Management, BRICS, Category Volume (Units), 2003-2017 19

Table 5: CSF Management, BRICS, Category Volume (Units), Historic, 2003-2010 21

Table 6: CSF Management, BRICS, Category Volume (Units), Forecast, 2010-2017 22

Table 7: CSF Management, BRICS, Company Share by Revenue ($m), 2009-2010 24

Table 8: CSF Management, Brazil, Overall Revenue ($m), 2003-2017 25

Table 9: CSF Management, Brazil, Revenue ($m), Historic, 2003-2010 26

Table 10: CSF Management, Brazil, Revenue ($m), Forecast, 2010-2017 28

Table 11: CSF Management, Brazil, Overall Volume (Units) 2003-2017 29

Table 12: CSF Management, Brazil, Volume (Units), Historic, 2003-2010 30

Table 13: CSF Management, Brazil, Volume (Units), Forecast, 2010-2017 31

Table 14: Dura Substitutes, Brazil, Revenue ($m), Historic, 2003-2010 32

Table 15: Dura Substitutes, Brazil, Revenue ($m), Forecast, 2010-2017 33

Table 16: Dura Substitutes, Brazil, Volume (Units), Historic, 2003-2010 34

Table 17: Dura Substitutes, Brazil, Volume (Units), Forecast, 2010-2017 35

Table 18: Dura Substitutes, Brazil, Average Price ($), Historic, 2003-2010 36

Table 19: Dura Substitutes, Brazil, Average Price ($), Forecast, 2010-2017 36

Table 20: Hydrocephalus Shunts, Brazil, Revenue ($m), Historic, 2003-2010 37

Table 21: Hydrocephalus Shunts, Brazil, Revenue ($m), Forecast, 2010-2017 38

Table 22: Hydrocephalus Shunts, Brazil, Volume (Units), Historic, 2003-2010 39

Table 23: Hydrocephalus Shunts, Brazil, Volume (Units), Forecast, 2010-2017 40

Table 24: Hydrocephalus Shunts, Brazil, Average Price ($), Historic, 2003-2010 41

Table 25: Hydrocephalus Shunts, Brazil, Average Price ($), Forecast, 2010-2017 41

Table 26: CSF Management, Brazil, Distribution Share by Revenue ($m), 2009-2010 42

Table 27: CSF Management, Brazil, Company Share by Revenue ($m), 2009-2010 44

Table 28: CSF Management, Russian Federation, Overall Revenue ($m), 2003-2017 45

Table 29: CSF Management, Russian Federation, Revenue ($m), Historic, 2003-2010 47

Table 30: CSF Management, Russian Federation, Revenue ($m), Forecast, 2010-2017 48

Table 31: CSF Management, Russian Federation, Overall Volume (Units), 2003-2017 49

Table 32: CSF Management, Russian Federation, Volume (Units), Historic, 2003-2010 51

Table 33: CSF Management, Russian Federation, Volume (Units), Forecast, 2010-2017 52

Table 34: Dura Substitutes, Russian Federation, Revenue ($m), Historic, 2003-2010 53

Table 35: Dura Substitutes, Russian Federation, Revenue ($m), Forecast, 2010-2017 54

Table 36: Dura Substitutes, Russian Federation, Volume (Units), Historic, 2003-2010 55

Table 37: Dura Substitutes, Russian Federation, Volume (Units), Forecast, 2010-2017 56

Table 38: Dura Substitutes, Russian Federation, Average Price ($), Historic, 2003-2010 57

Table 39: Dura Substitutes, Russian Federation, Average Price ($), Forecast, 2010-2017 57

Table 40: Hydrocephalus Shunts, Russian Federation, Revenue ($m), Historic, 2003-2010 58

Table 41: Hydrocephalus Shunts, Russian Federation, Revenue ($m), Forecast, 2010-2017 59

Table 42: Hydrocephalus Shunts, Russian Federation, Volume (Units), Historic, 2003-2010 60

Table 43: Hydrocephalus Shunts, Russian Federation, Volume (Units), Forecast, 2010-2017 61

Table 44: Hydrocephalus Shunts, Russian Federation, Average Price ($), Historic, 2003-2010 62

Table 45: Hydrocephalus Shunts, Russian Federation, Average Price ($), Forecast, 2010-2017 62

Table 46: CSF Management, Russian Federation, Distribution Share by Revenue ($m), 2009-2010 63

Table 47: CSF Management, Russian Federation, Company Share by Revenue ($m), 2009-2010 64

Table 48: CSF Management, India, Overall Revenue ($m), 2003-2017 65

Table 49: CSF Management, India, Revenue ($m), Historic, 2003-2010 67

Table 50: CSF Management, India, Revenue ($m), Forecast, 2010-2017 69

Table 51: CSF Management, India, Overall Volume (Units), 2003-2017 70

Table 52: CSF Management, India, Volume (Units), Historic, 2003-2010 71

Table 53: CSF Management, India, Volume (Units), Forecast, 2010-2017 72

Table 54: Dura Substitutes, India, Revenue ($m), Historic, 2003-2010 73

Table 55: Dura Substitutes, India, Revenue ($m), Forecast, 2010-2017 74

Table 56: Dura Substitutes, India, Volume (Units), Historic, 2003-2010 75

Table 57: Dura Substitutes, India, Volume (Units), Forecast, 2010-2017 76

Table 58: Dura Substitutes, India, Average Price ($), Historic, 2003-2010 77

Table 59: Dura Substitutes, India, Average Price ($), Forecast, 2010-2017 77

Table 60: Hydrocephalus Shunts, India, Revenue ($m), Historic, 2003-2010 78

Table 61: Hydrocephalus Shunts, India, Revenue ($m), Forecast, 2010-2017 79

Table 62: Hydrocephalus Shunts, India, Volume (Units), Historic, 2003-2010 80

Table 63: Hydrocephalus Shunts, India, Volume (Units), Forecast, 2010-2017 81

Table 64: Hydrocephalus Shunts, India, Average Price ($), Historic, 2003-2010 82

Table 65: Hydrocephalus Shunts, India, Average Price ($), Forecast, 2010-2017 82

Table 66: CSF Management, India, Distribution Share by Revenue ($m), 2009-2010 83

Table 67: CSF Management, India, Company Share by Revenue ($m), 2009-2010 84

Table 68: CSF Management, China, Overall Revenue ($m), 2003-2017 85

Table 69: CSF Management, China, Revenue ($m) by Historic, 2003-2010 87

Table 70: CSF Management, China, Revenue ($m), Forecast, 2010-2017 89

Table 71: CSF Management, China, Overall Volume (Units), 2003-2017 90

Table 72: CSF Management, China, Volume (Units), Historic, 2003-2010 91

Table 73: CSF Management, China, Volume (Units), Forecast, 2010-2017 92

Table 74: Dura Substitutes, China, Revenue ($m), Historic, 2003-2010 93

Table 75: Dura Substitutes, China, Revenue ($m), Forecast, 2010-2017 94

Table 76: Dura Substitutes, China, Volume (Units), Historic, 2003-2010 95

Table 77: Dura Substitutes, China, Volume (Units), Forecast, 2010-2017 96

Table 78: Dura Substitutes, China, Average Price ($), Historic, 2003-2010 97

Table 79: Dura Substitutes, China, Average Price ($), Forecast, 2010-2017 97

Table 80: Hydrocephalus Shunts, China, Revenue ($m), Historic, 2003-2010 98

Table 81: Hydrocephalus Shunts, China, Revenue ($m), Forecast, 2010-2017 99

Table 82: Hydrocephalus Shunts, China, Volume (Units), Historic, 2003-2010 100

Table 83: Hydrocephalus Shunts, China, Volume (Units), Forecast, 2010-2017 101

Table 84: Hydrocephalus Shunts, China, Average Price ($), Historic, 2003-2010 102

Table 85: Hydrocephalus Shunts, China, Average Price ($), Forecast, 2010-2017 102

Table 86: CSF Management, China, Distribution Share by Revenue ($m), 2009-2010 103

Table 87: CSF Management, China, Company Share by Revenue ($m), 2009-2010 105

Table 88: CSF Management, South Africa, Overall Revenue ($m), 2003-2017 106

Table 89: CSF Management, South Africa, Revenue ($m), Historic, 2003-2010 107

Table 90: CSF Management, South Africa, Revenue ($m), Forecast, 2010-2017 108

Table 91: CSF Management, South Africa, Overall Volume (Units), 2003-2017 109

Table 92: CSF Management, South Africa, Volume (Units), Historic, 2003-2010 110

Table 93: CSF Management, South Africa, Volume (Units), Forecast, 2010-2017 111

Table 94: Dura Substitutes, South Africa, Revenue ($m), Historic, 2003-2010 112

Table 95: Dura Substitutes, South Africa, Revenue ($m), Forecast, 2010-2017 113

Table 96: Dura Substitutes, South Africa, Volume (Units), Historic, 2003-2010 114

Table 97: Dura Substitutes, South Africa, Volume (Units), Forecast, 2010-2017 115

Table 98: Dura Substitutes, South Africa, Average Price ($), Historic, 2003-2010 116

Table 99: Dura Substitutes, South Africa, Average Price ($), Forecast, 2010-2017 116

Table 100: Hydrocephalus Shunts, South Africa, Revenue ($m), Historic, 2003-2010 117

Table 101: Hydrocephalus Shunts, South Africa, Revenue ($m), Forecast, 2010-2017 118

Table 102: Hydrocephalus Shunts, South Africa, Volume (Units), Historic, 2003-2010 119

Table 103: Hydrocephalus Shunts, South Africa, Volume (Units), Forecast, 2010-2017 120

Table 104: Hydrocephalus Shunts, South Africa, Average Price ($), Historic, 2003-2010 121

Table 105: Hydrocephalus Shunts, South Africa, Average Price ($), Forecast, 2010-2017 121

Table 106: CSF Management, South Africa, Distribution Share by Revenue ($m), 2009-2010 122

Table 107: CSF Management, South Africa, Company Share by Revenue ($m), 2009-2010 124

Table 108: Medtronic, Inc., Revenue ($m), BRICS CSF Management Market, 2010 126

Table 109: Integra LifeSciences Holdings Corporation, Revenue ($m), BRICS CSF Management Market, 2010 128

Table 110: B. Braun Melsungen AG, Revenue ($m), BRICS CSF Management Market, 2010 130

Table 111: Sophysa S.A., Revenue ($m), BRICS CSF Management Market, 2010 132

Table 112: USD to Local Currency, BRICS, Average Exchange Rate 2003-2010 137

1.2

List of Figures

Figure 1: CSF Management, BRICS, Overall Revenue ($m), 2003-2017 13

Figure 2: CSF Management, BRICS, Overall Revenue ($m), Historic, 2003-2010 15

Figure 3: CSF Management, BRICS, Overall Revenue ($m), Forecast, 2010-2017 17

Figure 4: CSF Management, BRICS, Category Volume (Units), 2003-2017 19

Figure 5: CSF Management, BRICS, Category Volume (Units), Historic, 2003-2010 20

Figure 6: CSF Management, BRICS, Category Volume (Units), Forecast, 2010-2017 22

Figure 7: CSF Management, BRICS, Company Share (%), 2010 23

Figure 8: CSF Management, Brazil, Overall Revenue ($m), 2003-2017 25

Figure 9: CSF Management, Brazil, Revenue ($m), Historic, 2003-2010 26

Figure 10: CSF Management, Brazil, Revenue ($m), Forecast, 2010-2017 27

Figure 11: CSF Management, Brazil, Overall Volume (Units), 2003-2017 29

Figure 12: CSF Management, Brazil, Volume (Units), Historic, 2003-2010 30

Figure 13: CSF Management, Brazil, Volume (Units), Forecast, 2010-2017 31

Figure 14: Dura Substitutes, Brazil, Revenue ($m), Historic, 2003-2010 32

Figure 15: Dura Substitutes, Brazil, Revenue ($m), Forecast, 2010-2017 33

Figure 16: Dura Substitutes, Brazil, Volume (Units), Historic, 2003-2010 34

Figure 17: Dura Substitutes, Brazil, Volume (Units), Forecast, 2010-2017 35

Figure 18: Hydrocephalus Shunts, Brazil, Revenue ($m), Historic, 2003-2010 37

Figure 19: Hydrocephalus Shunts, Brazil, Revenue ($m), Forecast, 2010-2017 38

Figure 20: Hydrocephalus Shunts, Brazil, Volume (Units), Historic, 2003-2010 39

Figure 21: Hydrocephalus Shunts, Brazil, Volume (Units), Forecast, 2010-2017 40

Figure 22: CSF Management, Brazil, Company Share (%), 2010 43

Figure 23: CSF Management, Russian Federation, Overall Revenue ($m), 2003-2017 45

Figure 24: CSF Management, Russian Federation, Revenue ($m), Historic, 2003-2010 46

Figure 25: CSF Management, Russian Federation, Revenue ($m), Forecast, 2010-2017 48

Figure 26: CSF Management, Russian Federation, Overall Volume (Units), 2003-2017 49

Figure 27: CSF Management, Russian Federation, Volume (Units), Historic, 2003-2010 50

Figure 28: CSF Management, Russian Federation, Volume (Units), Forecast, 2010-2017 52

Figure 29: Dura Substitutes, Russian Federation, Revenue ($m), Historic, 2003-2010 53

Figure 30: Dura Substitutes, Russian Federation, Revenue ($m), Forecast, 2010-2017 54

Figure 31: Dura Substitutes, Russian Federation, Volume (Units), Historic, 2003-2010 55

Figure 32: Dura Substitutes, Russian Federation, Volume (Units), Forecast, 2010-2017 56

Figure 33: Hydrocephalus Shunts, Russian Federation, Revenue ($m), Historic, 2003-2010 58

Figure 34: Hydrocephalus Shunts, Russian Federation, Revenue ($m), Forecast, 2010-2017 59

Figure 35: Hydrocephalus Shunts, Russian Federation, Volume (Units), Historic, 2003-2010 60

Figure 36: Hydrocephalus Shunts, Russian Federation, Volume (Units), Forecast, 2010-2017 61

Figure 37: CSF Management, Russian Federation, Company Share (%), 2010 64

Figure 38: CSF Management, India, Overall Revenue ($m), 2003-2017 65

Figure 39: CSF Management, India, Revenue ($m), Historic, 2003-2010 66

Figure 40: CSF Management, India, Revenue ($m), Forecast, 2010-2017 68

Figure 41: CSF Management, India, Overall Volume (Units), 2003-2017 70

Figure 42: CSF Management, India, Volume (Units), Historic, 2003-2010 71

Figure 43: CSF Management, India, Volume (Units), Forecast, 2010-2017 72

Figure 44: Dura Substitutes, India, Revenue ($m), Historic, 2003-2010 73

Figure 45: Dura Substitutes, India, Revenue ($m), Forecast, 2010-2017 74

Figure 46: Dura Substitutes, India, Volume (Units), Historic, 2003-2010 75

Figure 47: Dura Substitutes, India, Volume (Units), Forecast, 2010-2017 76

Figure 48: Hydrocephalus Shunts, India, Revenue ($m), Historic, 2003-2010 78

Figure 49: Hydrocephalus Shunts, India, Revenue ($m), Forecast, 2010-2017 79

Figure 50: Hydrocephalus Shunts, India, Volume (Units), Historic, 2003-2010 80

Figure 51: Hydrocephalus Shunts, India, Volume (Units), Forecast, 2010-2017 81

Figure 52: CSF Management, India, Company Share (%), 2010 84

Figure 53: CSF Management, China, Overall Revenue ($m), 2003-2017 85

Figure 54: CSF Management, China, Revenue ($m), Historic, 2003-2010 86

Figure 55: CSF Management, China, Revenue ($m), Forecast, 2010-2017 88

Figure 56: CSF Management, China, Overall Volume (Units), 2003-2017 90

Figure 57: CSF Management, China, Volume (Units), Historic, 2003-2010 91

Figure 58: CSF Management, China, Volume (Units), Forecast, 2010-2017 92

Figure 59: Dura Substitutes, China, Revenue ($m), Historic, 2003-2010 93

Figure 60: Dura Substitutes, China, Revenue ($m), Forecast, 2010-2017 94

Figure 61: Dura Substitutes, China, Volume (Units), Historic, 2003-2010 95

Figure 62: Dura Substitutes, China, Volume (Units), Forecast, 2010-2017 96

Figure 63: Hydrocephalus Shunts, China, Revenue ($m), Historic, 2003-2010 98

Figure 64: Hydrocephalus Shunts, China, Revenue ($m), Forecast, 2010-2017 99

Figure 65: Hydrocephalus Shunts, China, Volume (Units), Historic, 2003-2010 100

Figure 66: Hydrocephalus Shunts, China, Volume (Units), Forecast, 2010-2017 101

Figure 67: CSF Management, China, Company Share (%), 2010 104

Figure 68: CSF Management, South Africa, Overall Revenue ($m), 2003-2017 106

Figure 69: CSF Management, South Africa, Revenue ($m), Historic, 2003-2010 107

Figure 70: CSF Management, South Africa, Revenue ($m), Forecast, 2010-2017 108

Figure 71: CSF Management, South Africa, Overall Volume(Units), 2003-2017 109

Figure 72: CSF Management, South Africa, Volume (Units), Historic, 2003-2010 110

Figure 73: CSF Management, South Africa, Volume (Units), Forecast, 2010-2017 111

Figure 74: Dura Substitutes, South Africa, Revenue ($m), Historic, 2003-2010 112

Figure 75: Dura Substitutes, South Africa, Revenue ($m), Forecast, 2010-2017 113

Figure 76: Dura Substitutes, South Africa, Volume (Units), Historic, 2003-2010 114

Figure 77: Dura Substitutes, South Africa, Volume (Units), Forecast, 2010-2017 115

Figure 78: Hydrocephalus Shunts, South Africa, Revenue ($m), Historic, 2003-2010 117

Figure 79: Hydrocephalus Shunts, South Africa, Revenue ($m), Forecast, 2010-2017 118

Figure 80: Hydrocephalus Shunts, South Africa, Volume (Units), Historic, 2003-2010 119

Figure 81: Hydrocephalus Shunts, South Africa, Volume (Units), Forecast, 2010-2017 120

Figure 82: CSF Management, South Africa, Company Share (%), 2010 123

Figure 83: Medtronic, Inc., Company Share (%), BRICS CSF Management Market, 2010 126

Figure 84: Integra LifeSciences Holdings Corporation, Company Share (%), BRICS CSF Management Market, 2010 128

Figure 85: B. Braun Melsungen AG, Company Share (%), BRICS CSF Management Market, 2010 130

Figure 86: Sophysa S.A., Company Share (%), BRICS CSF Management Market, 2010 132

Companies Mentioned

Medtronic, Inc.

Integra LifeSciences Holdings Corporation

B. Braun Melsungen AG

Sophysa S.A.

To order this report:

Pathology Industry: Cerebrospinal Fluid (CSF) Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Pathology Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker